BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36707944)

  • 1. [Parameningeal or non-parameningeal head and neck rhabdomyosarcoma: a study based on propensity score matching and survival analysis].
    Tao YJ; Zhen HN; Guan H; Shen J; Zhang FQ; Liu ZK
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1409-1417. PubMed ID: 36707944
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 3. Pediatric head and neck rhabdomyosarcoma: An analysis of treatment and survival in the United States (1975-2016).
    Darwish C; Shim T; Sparks AD; Chillakuru Y; Strum D; Benito DA; Monfared A
    Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110403. PubMed ID: 33049553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and the prognosis of rhabdomyosarcoma - a report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
    Suita S; Noguchi S; Takamatsu H; Mizote H; Nagasaki A; Inomata Y; Hara T; Okamura J; Miyazaki S; Kawakami K; Eguchi H; Tsuneyoshi M;
    Eur J Pediatr Surg; 2005 Dec; 15(6):409-13. PubMed ID: 16418958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study Group.
    Walterhouse DO; Pappo AS; Baker KS; Parham DM; Anderson JR; Donaldson SS; Paidas CN; Womer RB; Crist WM
    Cancer; 2001 Dec; 92(12):3135-46. PubMed ID: 11753993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV.
    Baker KS; Anderson JR; Link MP; Grier HE; Qualman SJ; Maurer HM; Breneman JC; Wiener ES; Crist WM
    J Clin Oncol; 2000 Jun; 18(12):2427-34. PubMed ID: 10856103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyosarcoma of the head and neck in children: review and update.
    Reilly BK; Kim A; Peña MT; Dong TA; Rossi C; Murnick JG; Choi SS
    Int J Pediatr Otorhinolaryngol; 2015 Sep; 79(9):1477-83. PubMed ID: 26231745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retrospective study of 70 cases with the head and neck non-parameningeal rhabdomyosarcoma].
    Zhang G; Wang SC; Su Y; Liu ZK; Yu GX; Zhang J; Mei L; Sun N; Li YZ; Zhang XX; Liu QY; Liu ZY; Li XD; Ni X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Feb; 59(2):133-139. PubMed ID: 38369791
    [No Abstract]   [Full Text] [Related]  

  • 9. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data.
    Turner JH; Richmon JD
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):967-73. PubMed ID: 21873599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
    Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group.
    Raney B; Anderson J; Breneman J; Donaldson SS; Huh W; Maurer H; Michalski J; Qualman S; Ullrich F; Wharam M; Meyer W;
    Pediatr Blood Cancer; 2008 Jul; 51(1):17-22. PubMed ID: 18266224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and prognostic analysis of
    Zhao D; Lyu XM; Chen P; Shi Y; Huang MW; Zheng L; Zhao WH; Ma XL; Zhang JG
    Zhonghua Yi Xue Za Zhi; 2022 May; 102(20):1500-1505. PubMed ID: 35692064
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
    Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyosarcoma of the maxillofacial region in children and adolescents: Report of 9 cases and literature review.
    Iatrou I; Theologie-Lygidakis N; Schoinohoriti O; Tzermpos F; Vessala AM
    J Craniomaxillofac Surg; 2017 Jun; 45(6):831-838. PubMed ID: 28431807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-year relapse-free survival rates in childhood rhabdomyosarcoma of the head and neck: report from the Intergroup Rhabdomyosarcoma Study.
    Sutow WW; Lindberg RD; Gehan EA; Ragab AH; Raney RB; Ruymann F; Soule EH
    Cancer; 1982 Jun; 49(11):2217-21. PubMed ID: 7074538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.
    Raney RB; Meza J; Anderson JR; Fryer CJ; Donaldson SS; Breneman JC; Fitzgerald TJ; Gehan EA; Michalski JM; Ortega JA; Qualman SJ; Sandler E; Wharam MD; Wiener ES; Maurer HM; Crist WM
    Med Pediatr Oncol; 2002 Jan; 38(1):22-32. PubMed ID: 11835233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhabdomyosarcoma of the head and neck in children.
    Hicks J; Flaitz C
    Oral Oncol; 2002 Jul; 38(5):450-9. PubMed ID: 12110339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in head and neck rhabdomyosarcoma.
    Simon JH; Paulino AC; Smith RB; Buatti JM
    Head Neck; 2002 May; 24(5):468-73. PubMed ID: 12001077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.
    Owosho AA; Huang SC; Chen S; Kashikar S; Estilo CL; Wolden SL; Wexler LH; Huryn JM; Antonescu CR
    Oral Oncol; 2016 Oct; 61():89-97. PubMed ID: 27688110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) - RMS2005 study.
    Glosli H; Bisogno G; Kelsey A; Chisholm JC; Gaze M; Kolb F; McHugh K; Shipley J; Gallego S; Merks JHM; Smeele LE; Mandeville H; Ferrari A; Minard-Colin V; Corradini N; Jenney M; Zanetti I; De Salvo GL; Orbach D;
    Eur J Cancer; 2021 Jul; 151():84-93. PubMed ID: 33971448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.